MétaCan
Menu
Back to cohort
Record W2560660870 · doi:10.18433/j3sc8x

Predicting High-Impact Pharmacological Targets by Integrating Transcriptome and Text-Mining Features

2016· article· en· W2560660870 on OpenAlexvenueno aff
Anatoly Mayburd, Ancha Baranova

Bibliographic record

VenueJournal of Pharmacy & Pharmaceutical Sciences · 2016
Typearticle
Languageen
FieldComputer Science
TopicComputational Drug Discovery Methods
Canadian institutionsnot available
Fundersnot available
KeywordsTranscriptomeComputational biologyComputer scienceBiologyGeneticsGene expressionGene

Abstract

fetched live from OpenAlex

PURPOSE: Novel, "outside of the box" approaches are needed for evaluating candidate molecules, especially in oncology. Throughout the years of 2000-2010, the efficiency of drug development fell to barely acceptable levels, and in the second decade of this century, levels have improved only marginally. This dismal condition continues despite unprecedented progress in the development of a variety of high-throughput tools, computational methods, aggregated databases, drug repurposing programs and innovative chemistries. Here we tested a hypothesis that the economic impact of targeting a particular gene product is predictable a priori by employing a combination of transcriptome profiles and quantitative metrics reflecting existing literature. METHODS: To extract classification features, the gene expression patterns of a posteriori high-impact and low-impact anti-cancer target sets were compared. To minimize the possible bias of text-mining, the number of manuscripts published prior to the first clinical trial or relevant review paper, as well as its first derivative in this interval, were collected and used as quantitative metrics of public interest. RESULTS: By combining the gene expression and literature mining features, a 4-fold enrichment in high-impact targets was produced, resulting in a favourable ROC curve analysis for the top impact targets. The dataset was enriched by the highest impact anti-cancer targets, while demonstrating drastic differences in economic value between high and low-impact targets. Known anti-cancer products of EGFR, ERBB2, CYP19A1/aromatase, MTOR, PTGS2, tubulin, VEGFA, BRAF, PGR, PDGFRA, SRC, REN, CSF1R, CTLA4 and HSP90AA1 genes received the highest scores for predicted impact, while microsomal steroid sulfatase, anticoagulant protein C, p53, CDKN2A, c-Jun, and TNSFS11 were highlighted as most promising research-stage targets. CONCLUSIONS: A significant cost reduction may be achieved by a priori impact assessment of targets and ligands before their development or repurposing. Expanding a suite of combinational treatments could also decrease the costs, while achieving a higher impact per developed ligand. This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.007
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0070.004
Science and technology studies0.0000.000
Scholarly communication0.0020.001
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0010.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.054
GPT teacher head0.417
Teacher spread0.363 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSimulation or modeling
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Pharmacy & Pharmaceutical SciencesSame topicComputational Drug Discovery MethodsFrench-language works237,207